NOTE: This is a frame enhanced page. Best viewed in a web browser that supports frames (e.g. Netscape or Internet Explorer).
MECHANISMS OF DRUG ACTION
Table of Contents
Select a slide or start at the
beginning
.
MECHANISMS OF DRUG ACTION
(Untitled)
(Untitled)
SIDE EFFECTS
SIDE EFFECTS
ADVERSE EFFECTS
(Untitled)
PHARMACOLOGY
(Untitled)
BIOPHARMACEUTICS
BIOPHARMACEUTIC PHASE
MECHANISMS OF DRUG ACTION
(Untitled)
(Untitled)
PHARMACOKINETICS
PHARMACOKINETICS
TERMINOLOGY
(Untitled)
(Untitled)
(Untitled)
(Untitled)
PHARMACOKINETICS
DRUG ABSORPTION
(Untitled)
PLASMA PROTEIN BINDING
PROTEIN BINDING
(Untitled)
(Untitled)
BIOTRANSFORMATION
ELIMINATION
(Untitled)
BEST-CHARACTERIZED CYTOCHROMES P-450
DRUGS METABOLIZED BY CYP 2D6
DRUGS INDUCING CYP 2D6
DRUGS METABOLIZED BY CYP 3A3/4
DRUGS INHIBITING CYP 3A3/4
DRUGS INDUCING CYP 3A3/4
DRUGS METABOLIZED BY CYP 1A2
METABOLISM
(Untitled)
DISTRIBUTION
DISTRIBUTION
DISTRIBUTION
(Untitled)
EXCRETION
RENAL ELIMINATION
EXCRETION TYPES
EXCRETION TYPES
(Untitled)
EXCRETION TYPES
EXCRETION TYPES
EXCRETION TYPES
EXCRETION
(Untitled)
PHARMACODYNAMICS
RECEPTORS
(Untitled)
RECEPTOR
RECEPTOR
(Untitled)
(Untitled)
TRANSMEMBRANE SIGNALING
TRANSMEMBRANE SIGNALING
(Untitled)
(Untitled)
(Untitled)
(Untitled)
L-type Channel Model
(Untitled)
PHARMACODYNAMICS
(Untitled)
(Untitled)
PHARMACODYNAMICS
PHARMACODYNAMICS
PHARMACODYNAMICS
PHARMACODYNAMICS
(Untitled)
PHARMACODYNAMICS
Back to
Home Page
Comments or Questions?